13fxuM

FX Update: EM strains, Covid19 exit path questions dominate

Forex 4 minutes to read

Summary:  The Trump administration is doing its best to talk up the oil price, but we still see CAD at further downside risk here and we are noting considerable signs of strain across EM. Finally, as we head into the weekend, breaking news of Covid19-related shutdowns in Singapore today suggest post-virus outbreak exit paths will prove difficult.


I will continue with the quick FX update for now as our usual morning output takes up all of my bandwidth in the early hours, including our morning QuickTake and the Saxo Market Call podcast. On that note, here are our key focus points for today.

Its not the data right now, it’s the expectations for an exit path. Yesterday’s astonishing 6.6 million in US initial weekly jobless claims showed two things

  • One: the incredible scale of job losses and the fact that the US unemployment rate will spike far higher than its worst level since the global financial crisis, which was 10.8% in 1982 (Interesting to note that during the global financial crisis the top was far more “rounded” than the 1982 episode, peaking at 10.0% but not falling below 8% until almost three years later in 2012. After the late 1982 spike to 10.8%, the 8% level was reached in early 1984  a mere 15 months later – as the US economy at the time had a far different composition and far more factory/production workers relative to service jobs. This time around, with even more generous benefits for the unemployed, the fall in unemployment from an even higher peak could prove even slower – more on that in future updates)
  • Two: It’s not about the data right now. This is the single most horrifying number I have seen in my adult life, and yet elicited no market reaction on release. This shows more than anything that it is about the exit path from Covid19, not about the next month or two of data the market is discounting has already discounted as historic and unprecedented. On that note, it is disconcerting this morning that Singapore is announcing a new lockdown, closing all schools except for distance learning and most workplaces. This is not the “post-Covid19 model” the market was looking for earlier.

Still focusing on CAD: absolutely crazy gyrations in oil markets yesterday as US President Trump tried to talk up the prospects for major output cuts, but as our Ole Hansen points out, shutting in production is a difficult thing to do and can compromise the long term ability to resume production down the road.  This morning, Trump was at it again, and oil prices tried to rally. Regardless, we continue to focus on the damage done and ongoing for CAD in particular from this episode of weak prices and where the Canadian economy was as it entered this crisis, also discussed yesterday. It will take far more to shake us from our bearish conviction on CAD and the risk of further upside in USDCAD before we have reached a cycle top.(By the way, note that after a huge spike yesterday in crude oil futures for the longer term, say December of this year, ended the day in the middle of the range of two days ago – i.e., unchanged).

Next Tuesday next test for EUR – we have discussed the political risks in the EU Rising on its response to the Covid19 crisis in recent days – the next key test is the Eurogroup meeting (of EU finance ministers) next Tuesday.  EURJPY and EURUSD perhaps equally viable options for testing risks of existential cracks opening up again the in euro, even if the ECB is keeping the evident risk in sovereign bond spreads within the EU, etc. very orderly at the moment. The EURJPY pair is a bit closer to the key cycle lows over the past couple of sessions down around 116.00-25.

EM strains are getting grave in places – some of the weaker links across EM are a growing concern, especially ZAR and TRY, where in the former case, the ZAR is suffering an aggressive depreciation and the CDS price (insurance against default on sovereign S. African bonds) has risen sharply to new cycle highs close to 500 bps today from below 200 bps before the Covid19 outbreak dominated market attention. For Turkey, we use the forward implied yields and implied points to show that the market is already pricing in an aggressive further TRY depreciation. Yesterday, USDTRY 1-month forwards hit 35% (annualized). We also note HUF weakness as Hungary’s Orban now rules the country by decree.

Upcoming Economic Calendar Highlights (all times GMT)

  • 1230 – US Mar. Change in Nonfarm Payrolls
  • 1230 – US Mar. Average Hourly Earnings
  • 1230 – US Mar. Unemployment Rate
  • 1400 – US Mar. ISM Non-manufacturing

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.